Home » FDA Panel Barely OKs Wider Indication on Defibrillator
FDA Panel Barely OKs Wider Indication on Defibrillator
An FDA advisory panel voted 3-2 to expand the indication for Medtronic’s cardiac resynchronization therapy defibrillators to treat a milder form of heart failure.
MedPage Today
MedPage Today
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May